This finding may have clinical implications since chymase positive MCs increase in the alveolar compartment in several chronic respiratory diseases such as uncontrolled asthma, COPD and IPF [2,26] where parenchymal remodelling is an important feature. This evidence concerns the gene CMA1 and chronic obstructive pulmonary disease.